AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 74 filers reported holding AURINIA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $110,047 | -12.6% | 14,163 | +8.9% | 0.00% | 0.0% |
| Q2 2023 | $125,840 | -30.0% | 13,000 | -20.7% | 0.00% | -25.0% |
| Q1 2023 | $179,744 | -59.1% | 16,400 | -17.6% | 0.00% | -66.7% |
| Q3 2021 | $440,000 | -24.0% | 19,900 | -44.2% | 0.01% | -70.0% |
| Q2 2020 | $579,000 | +12.4% | 35,638 | +0.4% | 0.04% | -7.0% |
| Q1 2020 | $515,000 | -70.4% | 35,500 | -58.7% | 0.04% | -71.5% |
| Q4 2019 | $1,741,000 | +234.8% | 85,928 | +7.4% | 0.15% | +202.0% |
| Q1 2019 | $520,000 | +0.6% | 80,000 | +2.7% | 0.05% | -2.0% |
| Q3 2018 | $517,000 | +154.7% | 77,913 | +116.4% | 0.05% | +183.3% |
| Q2 2018 | $203,000 | +153.8% | 36,000 | +182.9% | 0.02% | +38.5% |
| Q3 2017 | $80,000 | -38.0% | 12,726 | -27.8% | 0.01% | -45.8% |
| Q1 2017 | $129,000 | +163.3% | 17,614 | +7.8% | 0.02% | +118.2% |
| Q3 2016 | $49,000 | – | 16,345 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Berry Street Capital Management LLP | 1,987,500 | $24,605,000 | 2.79% |
| NEA Management Company, LLC | 3,969,834 | $49,146,000 | 1.42% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 133,117 | $1,648,000 | 0.90% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 435,000 | $3,955,000 | 0.89% |
| ACT CAPITAL MANAGEMENT, LLC | 67,500 | $836,000 | 0.88% |
| Artal Group S.A. | 1,000,000 | $12,380,000 | 0.52% |
| CTC Capital Management, LLC | 12,800 | $158,000 | 0.42% |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 581,910 | $7,204,000 | 0.36% |
| Affinity Asset Advisors, LLC | 175,000 | $2,167,000 | 0.35% |
| Bellevue Group AG | 2,405,825 | $29,784,000 | 0.35% |